Orally Administered Isoflavones Are Present as Glucuronides in the Human Prostate

REFERENCES

• Jemal , A , Siegel , R , Ward , E , Murray , T , Xu , J Q and Thun , M J . 2007 . Cancer statistics, 2007 . CA Cancer J Clin , 57 : 43 – 66 .
   PubMed Web of Science ®Google Scholar
• Hill , C and Doyon , F . 2006 . The frequency of cancer in France in year 2002, and trends since 1968 . Bull Cancer , 93 : 7 – 11 .
   PubMedGoogle Scholar
• Messina , M J . 2003 . Emerging evidence on the role of soy in reducing prostate cancer risk . Nutr Rev , 61 : 117 – 131 .
   PubMed Web of Science ®Google Scholar
• Hsing , A W , Tsao , L and Devesa , S S . 2000 . International trends and patterns of prostate cancer incidence and mortality . Int J Cancer , 85 : 60 – 67 .
   PubMed Web of Science ®Google Scholar
• Shimizu , H , Ross , R K , Bernstein , L , Yatani , R Henderson , B E . 1991 . Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County . Br J Cancer , 63 : 963 – 966 .
   PubMed Web of Science ®Google Scholar
• Cook , L S , Goldoft , M , Schwartz , S M and Weiss , N S . 1999 . Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants . J Urol , 161 : 152 – 155 .
   PubMed Web of Science ®Google Scholar
• Sim , H G and Cheng , C WS . 2005 . Changing demography of prostate cancer in Asia . Eur J Cancer , 41 : 834 – 845 .
   PubMed Web of Science ®Google Scholar
• Yan , L and Spitznagel , E L . 2005 . Meta-analysis of soy food and risk of prostate cancer in men . Int J Cancer , 117 : 667 – 669 .
   PubMed Web of Science ®Google Scholar
• Pollard , M and Suckow , M A . 2006 . Dietary prevention of hormone refractory prostate cancer in Lobund-Wistar rats: a review of studies in a relevant animal model . Comp Med , 56 : 461 – 467 .
   PubMed Web of Science ®Google Scholar
• Magee , P J and Rowland , I R . 2004 . Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer . Br J Nutr , 91 : 513 – 531 .
   PubMed Web of Science ®Google Scholar
• Hempstock , J , Kavanagh , J P and George , N JR . 1998 . Growth inhibition of prostate cell lines in vitro by phyto-oestrogens . Br J Urol , 82 : 560 – 563 .
   PubMedGoogle Scholar
• Messina , M , Kucuk , O and Lampe , J W . 2006 . An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels . J AOAC Int , 89 : 1121 – 1134 .
   PubMed Web of Science ®Google Scholar
• Bemis , D L , Katz , A E and Buttyan , R . 2006 . Clinical trials of natural products as chemopreventive agents for prostate cancer . Expert Opin Investig Drugs , 15 : 1191 – 1200 .
   PubMed Web of Science ®Google Scholar
• Morrissey , C and Watson , R W . 2003 . Phytoestrogens and prostate cancer . Curr Drug Targets , 4 : 231 – 241 .
   PubMedGoogle Scholar
• Sarkar , F H and Li , Y . 2004 . The role of isoflavones in cancer chemoprevention . Front Biosci , 9 : 2714 – 2724 .
   PubMed Web of Science ®Google Scholar
• Al-Maharik , N and Botting , N P . 2006 . A facile synthesis of isoflavone 7-O-glucuronides . Tetrahedron Lett , 47 : 8703 – 8706 .
   Web of Science ®Google Scholar
• Messina , M , Nagata , C and Wu , A H . 2006 . Estimated Asian adult soy protein and isoflavone intakes . Nutr Cancer , 55 : 1 – 12 .
   PubMed Web of Science ®Google Scholar
• Manach , C , Williamson , G , Morand , C , Scalbert , A and Remesy , C . 2005 . Bioavailability and bioefficacy of polyphenols in humans: I. review of 97 bioavailability studies . Am J Clin Nutr , 81 : 230S – 242S .
   PubMed Web of Science ®Google Scholar
• Morton , M S , Chan , P S , Cheng , C , Blacklock , N Matos-Ferreira , A . 1997 . Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom . Prostate , 32 : 122 – 128 .
   PubMed Web of Science ®Google Scholar
• Hong , S J , Kim , S I , Kwon , S M , Lee , J R and Chung , B C . 2002 . Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia . Yonsei Med J , 43 : 236 – 241 .
   PubMed Web of Science ®Google Scholar
• Hedlund , T E , Maroni , P D , Ferucci , P G , Dayton , R Barnes , S . 2005 . Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in Caucasian men . J Nutr , 135 : 1400 – 1406 .
   PubMed Web of Science ®Google Scholar
• Rannikko , A , Petas , A , Rannikko , S and Adlercreutz , H . 2006 . Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestrogen supplementation . Prostate , 66 : 82 – 87 .
   PubMed Web of Science ®Google Scholar
• Setchell , K D , Brown , N M , Desai , P , Zimmer-Nechemias , L Wolfe , B E . 2001 . Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements . J Nutr , 131 : 1362S – 1375S .
   PubMed Web of Science ®Google Scholar
• Busby , M G , Jeffcoat , A R , Bloedon , L T , Koch , M A Black , T . 2002 . Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men . Am J Clin Nutr , 75 : 126 – 136 .
   PubMed Web of Science ®Google Scholar
• Zhang , Y , Hendrich , S and Murphy , P A . 2003 . Glucuronides are the main isoflavone metabolites in women . J Nutr , 133 : 399 – 404 .
   PubMed Web of Science ®Google Scholar
• Levsen , K , Schiebel , H M , Behnke , B , Dotzer , R Dreher , W . 2005 . Structure elucidation of phase II metabolites by tandem mass spectrometry: an overview . J Chromatogr A , 1067 : 55 – 72 .
   PubMed Web of Science ®Google Scholar
• de Graaf , M , Boven , E , Scheeren , H W , Haisma , H J and Pinedo , H M . 2002 . Beta-glucuronidase-mediated drug release . Curr Pharm Des , 8 : 1391 – 1403 .
   PubMed Web of Science ®Google Scholar
• Zhang , Y , Song , T T , Cunnick , J E , Murphy , P A and Hendrich , S . 1999 . Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations . J Nutr , 129 : 399 – 405 .
   PubMed Web of Science ®Google Scholar
• Turner , R , Baron , T , Wolffram , S , Minihane , A M Cassidy , A . 2004 . Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein . Free Radic Res , 38 : 209 – 216 .
   PubMed Web of Science ®Google Scholar
• Rimbach , G , Weinberg , P D , de Pascual-Teresa , S , Alonso , M G Ewins , B A . 2004 . Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function . Biochim Biophys Acta , 1670 : 229 – 237 .
   PubMed Web of Science ®Google Scholar
• Miltyk , W , Craciunescu , C N , Fischer , L , Jeffcoat , R A Koch , M A . 2003 . Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer . Am J Clin Nutr , 77 : 875 – 882 .
   PubMed Web of Science ®Google Scholar